Tectonic Therapeutic, Inc.
NASDAQ:TECX · NASDAQ Global Market
-$0.29 today
Vol 0.10M · Avg 0.20M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+60.11%
Period High
$35.87
Period Low
$14.71
Latest
$30.02
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alpha Tau Medical Ltd.
NASDAQ:DRTS
$868.76M
Alto Neuroscience, Inc.
NYSE:ANRO
$779.79M
DBV Technologies S.A.
NASDAQ:DBVT
$383.25M
Amarin Corporation plc
NASDAQ:AMRN
$337.34M
Silence Therapeutics plc
NASDAQ:SLN
$324.73M
Cellectis S.A.
NASDAQ:CLLS
$316.31M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$301.66M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$297.79M
AC Immune S.A.
NASDAQ:ACIU
$240.69M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$117.02M
What is the latest TECX filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does TECX have?
Intrinsic Alpha currently shows 20 recent filings for TECX.
Explore More
Continue the stock analysis
Jump to another research area for this company.